Literature DB >> 28429959

Reduced arteriovenous oxygen difference in heart failure with preserved ejection fraction patients: Is the muscle oxidative phenotype certainly involved?

David Montero1, Carsten Lundby2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28429959     DOI： 10.1177/2047487317706587

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN： 2047-4873            Impact factor:   7.804


× No keyword cloud information.
  3 in total

Review 1.  Beyond the myocardium? SGLT2 inhibitors target peripheral components of reduced oxygen flux in the diabetic patient with heart failure with preserved ejection fraction.

Authors:  Mouhamed Nashawi; Omar Sheikh; Ayman Battisha; Mahnoor Mir; Robert Chilton
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

2.  Hypovolemia and reduced hemoglobin mass in patients with heart failure and preserved ejection fraction.

Authors:  David Montero; Thomas Haider; Jens Barthelmes; Jens P Goetze; Silviya Cantatore; Isabella Sudano; Frank Ruschitzka; Andreas J Flammer
Journal:  Physiol Rep       Date:  2019-11

3.  Monitoring functional capacity in heart failure.

Authors:  Massimo F Piepoli; Ilaria Spoletini; Giuseppe Rosano
Journal:  Eur Heart J Suppl       Date:  2019-12-31       Impact factor: 1.803
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.